000			02030 a2200529 4500
005			20250516213208.0
264		0	_c20150527
008			201505s 0 0 eng d
022			_a1439-3646
024	7		_a10.1055/s-0034-1374586 _2doi
040			_aNLM _beng _cNLM
100	1		_aLi, C-J
245	0	0	_aEfficacy and safety comparison of add-on therapy with liraglutide, saxagliptin and vildagliptin, all in combination with current conventional oral hypoglycemic agents therapy in poorly controlled Chinese type 2 diabetes. _h[electronic resource]
260			_bExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association _cSep 2014
300			_a469-76 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial
650	0	4	_aAdamantane _xadverse effects
650	0	4	_aAdult
650	0	4	_aAsian People
650	0	4	_aBlood Glucose
650	0	4	_aBody Weight
650	0	4	_aChina
650	0	4	_aDiabetes Mellitus, Type 2 _xdrug therapy
650	0	4	_aDipeptides _xadverse effects
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGlucagon-Like Peptide 1 _xadverse effects
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xadverse effects
650	0	4	_aInsulin _xtherapeutic use
650	0	4	_aLiraglutide
650	0	4	_aMale
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aNitriles _xadverse effects
650	0	4	_aPyrrolidines _xadverse effects
650	0	4	_aTreatment Outcome
650	0	4	_aVildagliptin
700	1		_aYu, Q
700	1		_aYu, P
700	1		_aZhang, Q-M
700	1		_aDing, M
700	1		_aLiu, X-J
700	1		_aYu, D-M
773	0		_tExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association _gvol. 122 _gno. 8 _gp. 469-76
856	4	0	_uhttps://doi.org/10.1055/s-0034-1374586 _zAvailable from publisher's website
999			_c23834981 _d23834981